Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease

Rajan Sharma, David C. Gaze, Denis Pellerin, Rajnikant L. Mehta, Helen Gregson, Christopher P. Streather, Paul O. Collinson, Stephen J. D. Brecker

Open source

DOI
10.1042/cs20070015
Published
2007-06-01
Container
Clinical Science
Publisher
Portland Press Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1042/cs20070015,
  title = {Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease},
  author = {Rajan Sharma and David C. Gaze and Denis Pellerin and Rajnikant L. Mehta and Helen Gregson and Christopher P. Streather and Paul O. Collinson and Stephen J. D. Brecker},
  year = {2007},
  journal = {Clinical Science},
  doi = {10.1042/cs20070015},
  url = {https://doi.org/10.1042/cs20070015}
}

RIS

TY  - JOUR
TI  - Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease
AU  - Rajan Sharma
AU  - David C. Gaze
AU  - Denis Pellerin
AU  - Rajnikant L. Mehta
AU  - Helen Gregson
AU  - Christopher P. Streather
AU  - Paul O. Collinson
AU  - Stephen J. D. Brecker
PY  - 2007
JO  - Clinical Science
DO  - 10.1042/cs20070015
UR  - https://doi.org/10.1042/cs20070015
ER  - 

APA

Sharma, R., Gaze, D. C., Pellerin, D., Mehta, R. L., Gregson, H., Streather, C. P., Collinson, P. O., & Brecker, S. J. D. (2007). Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease. Clinical Science. https://doi.org/10.1042/cs20070015

Source records